TABASUM NAZIR: Open Payments
NPI 1992055750 · TROY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$126 in 6 payments from 2 companies in 2025. Trend: 2023 $339 · 2024 $249 · 2025 $126
Food & beverage: $126
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $102 |
| Astellas Pharma US Inc | 1 | $24 |
Products named: TRELEGY ELLIPTA, Veozah.
Industry payments across NY — which companies pay providers there.
